122
Participants
Start Date
June 26, 2015
Primary Completion Date
July 3, 2017
Study Completion Date
February 22, 2019
Carboplatin
Placebo
Trilaciclib
Etoposide
Orszagos Koranyi Tbc es Pulmonologiai Intezet, XI. Tudobelosztaly, Budapest
ARENSIA Exploratory Medicine Phase I Unit, The Institute of Oncology, Chisinau
Hetenyi Geza Korhaz, Szolnok
Veszprem Megyei Tudogyogyintezet, Farkasgyepű
Consorcio Hospitalario Provincial, Castillón
Roswell Park, Buffalo
Guthrie Medical Group, PC, Sayre
Thomas Jefferson University, Philadelphia
Center For Cancer and Blood Disorders, Bethesda
UNC - Lineberger Comprehensive Cancer Center, Chapel Hill
Hgu Gregorio Maranon, Madrid
Fundacion Jimenez Diaz, Madrid
Hospital Regional Universitario HRU Carlos Haya Malaga, Málaga
Gibbs Cancer Center, Spartanburg
Greenville Health System, Greenville
Emory University, Atlanta
University Cancer and Blood Center, LLC, Athens
Florida Cancer Specialists - North, Tavares
Florida Cancer Specialists - East, West Palm Beach
Boca Raton Regional Hospital - Lynn Cancer Institute, Boca Raton
Florida Cancer Specialists - South, Fort Myers
CHU de Rennes Hopital Pontchaillou, Rennes
Tennessee Cancer Specialists, Knoxville
Hanna Cancer Associates - University of Tennessee, Knoxville
Norton Cancer Institute, Louisville
Genesis Cancer Center, Hot Springs
Highlands Oncology Group, Rogers
Oklahoma University - Peggy and Charles Stephenson Cancer Center, Oklahoma City
Texas Oncology, Tyler
University of Colorado Health, Oncology Clinical Research Northern Region, Fort Collins
Memorial Hospital - Univ. of Colorado Health, Colorado Springs
University of New Mexico Comprehensive Cancer Center, Albuquerque
The Oncology Institute of Hope and Innovation, Whittier
Northwest Cancer Specialists, P.C., Vancouver
Norris Cotton Cancer Center, Lebanon
ARENSIA Exploratory Medicine LLC, Tbilisi
Samodzielny Publiczny ZespAA GruAicy i ChorAb PA¿uc, Olsztyn
Wojewodzki Szpital Zespolony im. L. Rydygiera, Torun
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw
Hospital de la Santa Creu i Sant Pau, Barcelona
Lead Sponsor
G1 Therapeutics, Inc.
INDUSTRY